Precigen, Inc.
A biopharmaceutical company in Germantown, Maryland, that develops precision medicines for cancer, autoimmune disorders, and infectious diseases. It grew out of Intrexon, a synthetic biology firm founded in 1998, and in 2020 the whole company rebranded as Precigen to focus entirely on human health. Its name blends "precision" and "genetics," and its UltraCAR-T platform can engineer a patient's own immune cells overnight at the hospital using a non-viral "Sleeping Beauty" gene-delivery system.
Granted 23.85M · Bought 62.35M · Sold 16.45M
Bought 6.76M · Sold 6.75M
Granted 6.12M · Bought 22.9K · Sold 1.15M
Granted 666.0K · Bought 577.2K
Granted 654.2K · Bought 400.0K
Granted 681.7K
Granted 1.13M · Bought 2.9K · Sold 257.4K
Granted 751.7K · Bought 88.4K · Sold 192.2K
Granted 685.4K
Granted 666.0K · Bought 3.0K
Granted 658.7K · Bought 90.8K · Sold 76.1K
Granted 469.3K · Bought 30.0K
Granted 644.0K · Bought 11.1K · Sold 64.1K
Granted 295.8K · Bought 32.9K
Granted 462.9K · Sold 122.9K
Granted 264.8K · Bought 41.0K
Granted 200.0K · Bought 100.0K
Granted 201.0K · Bought 2.4K · Sold 279.9K
Granted 696.9K · Bought 38.4K · Sold 556.5K
Granted 196.1K · Bought 6.0K · Sold 30.3K
Granted 113.3K · Bought 20.9K · Sold 20.9K
Granted 113.3K · Bought 20.9K · Sold 20.9K
Granted 23.5K · Bought 8.5K · Sold 82.7K
Granted 97.3K · Sold 23.3K
Granted 4.1K
Granted 37.9K · Sold 9.1K
Granted 23.5K · Bought 7.4K · Sold 4.1K
Bought 15.0K
Bought 4.0K
Bought 3.2K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Kirk Randal JDirector, 10% owner · 552 transactions | — | 117.45M | 23.85M | 62.35M | 16.45M |
| Ares Trading S.A.10% owner · 68 transactions | — | 20.65Mas of Oct 2021 | — | 6.76M | 6.75M |
| Sabzevari HelenPresident and CEO · 60 transactions | — | 3.77M | 6.12M | 22.9K | 1.15M |
| Hassan FredDirector · 20 transactions | — | 1.24M | 666.0K | 577.2K | — |
| Frank StevenDirector · 33 transactions | — | 1.23M | 654.2K | 400.0K | — |
| Alvarez Cesar LDirector · 31 transactions | — | 782.9K | 681.7K | — | — |
| Lehr Donald P.Chief Legal Officer · 59 transactions | — | 755.5K | 1.13M | 2.9K | 257.4K |
| Perez Jeffrey ThomasSVP, IP Affairs · 52 transactions | — | 743.1Kas of Aug 2024 | 751.7K | 88.4K | 192.2K |
| Turley James SDirector · 21 transactions | — | 685.4K | 685.4K | — | — |
| Gupta Vinita DDirector · 19 transactions | — | 666.0K | 666.0K | 3.0K | — |
| Thomasian Harry Jr.Chief Financial Officer · 25 transactions | — | 554.5K | 658.7K | 90.8K | 76.1K |
| Mitchell Dean JDirector · 26 transactions | — | 503.2Kas of Mar 2024 | 469.3K | 30.0K | — |
| Shah Rutul RChief Operating Officer · 20 transactions | — | 497.8K | 644.0K | 11.1K | 64.1K |
| Shapiro Robert BDirector · 25 transactions | — | 412.6Kas of Mar 2023 | 295.8K | 32.9K | — |
| Sterling Rick L.Chief Financial Officer · 30 transactions | — | 340.0Kas of Jan 2021 | 462.9K | — | 122.9K |
| Agee Nancy HDirector · 8 transactions | — | 305.8K | 264.8K | 41.0K | — |
| Frost Gregory IanSVP--Health Sector · 4 transactions | — | 300.0Kas of May 2015 | 200.0K | 100.0K | — |
| Reed Thomas D.Chief Science Officer · 26 transactions | — | 255.9Kas of Jan 2020 | 201.0K | 2.4K | 279.9K |
| Kindler Jeffrey BDirector · 36 transactions | — | 202.1K | 696.9K | 38.4K | 556.5K |
| Tennant PhilChief Commercial Officer · 8 transactions | — | 139.4K | 196.1K | 6.0K | 30.3K |
| Krishnan Krish SChief Operating Officer · 7 transactions | — | 113.3Kas of Jan 2016 | 113.3K | 20.9K | 20.9K |
| Krishnan SumaSVP--Product Development · 7 transactions | — | 113.3Kas of Jan 2016 | 113.3K | 20.9K | 20.9K |
| Liffman Joel DSVP, Finance · 5 transactions | — | 85.5Kas of Jan 2019 | 23.5K | 8.5K | 82.7K |
| Bostick ThomasChief Operating Officer · 13 transactions | — | 74.3Kas of Jan 2020 | 97.3K | — | 23.3K |
| Horner Larry D /FaDirector · 11 transactions | — | 68.5Kas of Mar 2015 | 4.1K | — | — |
| Walsh Robert F. IIISVP, Energy & Fine Chem. · 5 transactions | — | 28.8Kas of Jul 2019 | 37.9K | — | 9.1K |
| Nimrodi NirChief Business Officer · 5 transactions | — | 26.9Kas of Jan 2019 | 23.5K | 7.4K | 4.1K |
| Kasser Thomas R.SVP--Food Sector · 2 transactions | — | 15.0Kas of May 2014 | — | 15.0K | — |
| Webster DarrylSVP--Intellectual Property · 2 transactions | — | 8.6Kas of Aug 2013 | — | — | — |
| Last Andrew J.Chief Operating Officer · 2 transactions | — | 4.0Kas of Nov 2017 | — | 4.0K | — |
| Huang KellySVP-Consumer Sector · 1 transaction | — | 3.2Kas of May 2014 | — | 3.2K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: +44.54M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.